Physician profile
Fawaz Faisal
NPI 1487679361
$10,907.81
in general payments reported to CMS, 2019-2025
54 companies · $947 in 2025
The $947 reported for 2025 was more than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,048 · 2020: $899 · 2021: $1,869 · 2022: $1,814 · 2023: $889 · 2024: $1,443 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,265 · Education: $13.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,265.39 |
| Education | $13.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,157.93 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,013.51 | 2019-2025 | |
| Livanova USA, INC. | $809.83 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $797.00 | 2019-2024 | Rystiggo |
| Biogen, INC. | $577.64 | 2019-2025 | Vumerity, Tysabri |
| Inspire Medical Systems, INC. | $442.91 | 2024-2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $409.38 | 2019-2024 | Austedo Xr, Austedo |
| Acorda Therapeutics, INC | $357.66 | 2019 | |
| Amgen INC. | $339.86 | 2019-2024 | Uplizna |
| Harmony Biosciences LLC | $299.08 | 2020-2022 | |
| Emd Serono, INC. | $282.00 | 2019-2021 | |
| Allergan, INC. | $280.99 | 2019-2021 | |
| Lilly USA, LLC | $275.56 | 2019-2025 | Kisunla, Zepbound |
| Genzyme Corporation | $230.75 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $224.44 | 2019-2025 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fawaz Faisal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.